A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease

scientific article published on 01 March 2019

A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1167/IOVS.18-24935
P698PubMed publication ID30901389

P2093author name stringChae Eun Kim
Young-Joon Park
Hyesook Lee
Jaewook Yang
Sangwon Jeon
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 4.0 InternationalQ24082749
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjecteye diseaseQ3041498
P304page(s)1076-1087
P577publication date2019-03-01
P1433published inInvestigative Ophthalmology Visual ScienceQ6060707
P1476titleA New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease
P478volume60

Reverse relations

cites work (P2860)
Q91811467Contribution of Mucins towards the Physical Properties of the Tear Film: A Modern Update
Q98944947hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye

Search more.